Cefiderocol

Fetcroja 1 G Polvo Para Concentrado Para Solucion Para Perfusion

1563.8 mg polvo para concentrado para solución para perfusiónSpainMarketedAuthorised 1 Jun 2020

In other countries

The same active substances on other registers, the same brand first.

FetcrojaEuropean Union · Shionogi B.V.Same brand
FetcrojaCroatiaSame brand
FetcrojaItaly · Polvere per concentrato per soluzione per infusione · Shionogi BVSame brand
Fetcroja 1 g, poeder voor concentraat voor oplossing voor infusieNetherlands · Poeder voor concentraat voor oplossing voor infusie · Shionogi B.V.Same brand
FetrojaUnited States · 1GM BASE/VIAL · powder · ShionogiSame substance

Packs

Pack	Code	Status
FETCROJA 1 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION 10 viales	728609

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Cefiderocol

Fetcroja 1 G Polvo Para Concentrado Para Solucion Para Perfusion

1563.8 mg polvo para concentrado para solución para perfusiónSpainMarketedAuthorised 1 Jun 2020

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status
FETCROJA 1 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION 10 viales	728609

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Summary of product characteristicsAEMPS

Package leafletAEMPS

Register entryAEMPS

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Cefiderocol
Strength: 1563.8 mg
Dosage form: polvo para concentrado para solución para perfusión
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 1 Jun 2020
Registration: 1201434
Marketing authorisation holder: Shionogi B.V.
Procedure: EU centralised
Supply: Uso Hospitalario